Vincent O'Neill Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

Vincent O'Neill is Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 19,601 shares of BTAI, which is worth approximately $9,996. The most recent transaction as insider was on Oct 03, 2024, when has been sold 5,556 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $3,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.6K

456.21% 3M change

759.32% 12M change

Total Value Held $9,996

Vincent O'Neill Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2024	SELL Open market or private sale	$3,055 $0.55 p/Share	5,556 Reduced 22.09%	19,601 Common Stock
Sep 17 2024	BUY Grant, award, or other acquisition	-	21,250 Added 45.79%	25,157 Common Stock
Sep 16 2024	SELL Open market or private sale	$95 $0.69 p/Share	138 Reduced 3.41%	3,907 Common Stock
Sep 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 11.41%	4,045 Common Stock
Jun 17 2024	SELL Open market or private sale	$198 $1.28 p/Share	155 Reduced 4.21%	3,524 Common Stock
Jun 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 12.4%	3,679 Common Stock
Apr 04 2024	SELL Open market or private sale	$432 $2.62 p/Share	165 Reduced 2.96%	5,408 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	2,250 Added 28.76%	5,573 Common Stock
Mar 14 2024	BUY Exercise of conversion of derivative security	-	521 Added 13.55%	3,323 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	-	521 Added 15.68%	2,802 Common Stock
Sep 14 2023	BUY Exercise of conversion of derivative security	-	521 Added 18.59%	2,281 Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	-	521 Added 22.84%	1,760 Common Stock
Mar 15 2023	SELL Open market or private sale	$16,646 $19.7 p/Share	845 Reduced 40.55%	1,239 Common Stock
Mar 14 2023	BUY Exercise of conversion of derivative security	-	2,084 Added 50.0%	2,084 Common Stock
Jan 20 2023	SELL Open market or private sale	$891,390 $30.0 p/Share	29,713 Reduced 100.0%	0 Common Stock
Jan 20 2023	BUY Exercise of conversion of derivative security	$12,182 $0.41 p/Share	29,713 Added 50.0%	29,713 Common Stock
Feb 17 2021	SELL Open market or private sale	$1,387,750 $55.51 p/Share	25,000 Reduced 100.0%	0 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	$142,750 $5.71 p/Share	25,000 Added 50.0%	25,000 Common Stock
Jan 19 2021	SELL Open market or private sale	$1,260,000 $50.4 p/Share	25,000 Reduced 100.0%	0 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$10,250 $0.41 p/Share	25,000 Added 50.0%	25,000 Common Stock
Dec 28 2020	SELL Open market or private sale	$1,304,750 $52.19 p/Share	25,000 Reduced 100.0%	0 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$10,250 $0.41 p/Share	25,000 Added 50.0%	25,000 Common Stock

Vincent O'Neill

Officer

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

Operation

Value

Type

News

Receive news related to BioXcel Therapeutics, Inc.

Track Activities on BTAI

Account